Minimally invasive surgery ‘safe, valid’ alternative to open approach for pancreatic cancer

Minimally invasive surgery appeared safe and just as effective as open surgery for patients with resectable pancreatic cancer, according to results of the DIPLOMA trial scheduled for presentation at ASCO Annual Meeting.“This trial, which is the first trial of its kind, can confirm that minimally invasive distal pancreatectomy is a safe, valid and efficient alternative to the open approach in the treatment of resectable pancreatic cancer in the body and tail of the pancreas,” Mohammad Abu Hilal, MD, PhD, surgical director at Instituto Ospedaliero Fondazione Poliambulanza inRead More